Associated Papers
Genomic and clinical characteristics of MET exon14 alterations in a large cohort of Chinese cancer patients revealed distinct features and a novel resistance mechanism for crizotinib.
Cheng T et al.
Journal of Cancer, 2021
Select a paper to view details